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Introduction 
 
Cognition is the process by which the sensory input is transformed, reduced, elaborated, stored, recovered, and used. It can be divided into several functions, which have been qualified as low and high 
considering its complexity and distribution within animals and their sensorial and cognitive capabilities. 
 
Cognitive functions that derive from a more ancient phylogenetic origin: habituation and sensitization, inhibition of spontaneous behaviours, produce a behavioural response when presented to a neutral 
stimulus, reinforced procedural conditioning. Advance in the phylogenetic line and the brain becomes more developed it holds the ability to use information in a very specific manner: Cognitive mapping  
and Spatial mapping. 
Neuroplasticity 
 
The human brain is the most remarkable structure that we are aware of, it is capable of incredibly 
rapid processing speed, which enables us to understand complex information in our environment 
within a tenth of a second. Our brain is a massive structure and it has been estimated that it 
contains 1x1014 neurons in it which are interconnected by an even more massive number of 
connections, creating an incredibly network of unbelievable complexity.  
 
The brain is flexible and adaptable. This new idea brought the concept of neural plasticity which 
defines its ability to modify its function and structure in response to new experiences throughout 
life. An experiment run on London’s taxi drivers proved how their response and posteriors 
hippocampus changed over several months, after and during their training, in order to obtain the 
license, with a shockingly increase (Figure 2). The same happened in those persons that were 
asked to learn juggling; they were summited to brain scans in order to observe the modification 
that occurred in several visual areas (Figure 3). 
Neurodegeneration 
 
Progressive loss of structure and function of fragments of the network of neurons that composes the 
brain, the loss of biological integrity at the cellular level is what is called neurodegeneration. It is 
insidious after a certain period of normal function from the brain; it is relentless over years, 
sometimes even decades. 
 
Includes affections such as Parkinson’s disease, with a well-known loss of dopaminergic nigrostriatal 
neurons, Huntington’s disease characterized by a loss of spiny, medium-sized striatal neurons or 
Alzheimer’s dementia (Figure 1) due to diffuse cerebral atrophy. Also diseases like primary dystonia 
or essential tremor. 
Pharmacological improvement 
 
Cognition has always been associated to acetylcholine (ACh) as a neurotransmitter, yet it is also 
considered the effect of dopamine and serotonin.  These elements modify the response over 
information, and how, in conclusion, individuals respond to the information that their environment 
releases. Also, a hyper or hypo activity of these systems can cause several pathologies. 
Cognitive neuropharmacology is the discipline that studies the  action mechanisms and 
therapeutic use of determined drugs that have certain effect onto cognition. These drugs are 
divided into several different categories: 
1. Anxiolytic and hypnotic drugs: reduce several disorders related to anxiety such as panic, 
phobias, post-traumatic stress. Examples: benzodiazepines, buspirone, propranolol, zolpidem, 
barbiturates and several other miscellaneous substances. 
2. Antipsychotic drugs: used to treat schizophrenia and other similar pathologies related to 
mental illness. Examples: chlorpromazine, haloperidol, fluphenazine, flupenthixol, clopenthixol 
and the second clozapine, risperidone, sertindole, quetiapine, amisulpride, aripiprazoleand 
zotepine. 
3. Antidepressant drugs the inhibitors of the monoamine uptake (fluoxetine or fluvoxamin, 
maprotilina and reboxetine, imipramine and amitriptyline), also the monoamine oxidase 
inhibitors (MAOIs) (phelezine and moclobemide) and the miscellaneous receptor blocking 
compounds (mianserin and trazodone). 
4. Antiepileptic drugs: used to control seizures or treat and prevent convulsions caused by other 
brain diseases such as trauma, infections and brain tumors. Examples: phenytoin, 
carbamazepine and phenobarbital, various benzodiazepines, such as diazepam, clonazepam. 
Newer drugs include vigabatrin, gabapentin, lamotrigine, felbamate and tiagabine. 
 
Nootropics have been also referred as memory enhancers or cognitive enhancers. They can be 
from drugs to supplements that allow an improvement in mental functions such as cognition, 
memory, intelligence, motivation, attention and concentration. These elements, it is thought, they 
work altering the availability of the brain’s supply of neurochemicals, such as neurotransmitters, 
hormones and enzymes, and improving the supplies of oxygen into the brain. 
Non-Pharmacological improvement 
 
This area takes on an approach that allows the increase of an individual’s capabilities, without the 
use of pharmacological enhancers, exploiting the brain’s natural neural plasticity. These studies 
have focused in several points of our brain that may decrease over time and become limitations to 
our capacities: attention, working memory and speed. 
 
Attention is something that cannot be focused over a huge environment, it has to be directed and 
focused over a specific objective in order to obtain results. Working memory is the ability to hold 
information in mind, for short periods of time and use it to guide our behaviour. Processing speed 
depends in the processing of information at high speeds but, they never work by themselves.. This, 
causes the generation of a lag in information processing that slows down the velocity in which 
information goes through the brain . 
The brains reaction and response becomes affected highly but the ever slightest interference; even 
the regular environment in which we are exposed to starts to cause these interferences. All these 
negative influences over the brain result in a reduced working memory and long term memory. 
 
Games of strategic kind, with rules and tricks to perform an action allows the development of new 
pathways to solve more challenging difficulties that might be presented later. Action videogames 
can improve resistance to distraction and capacity of attention, allowing for an improvement in the 
brain’s limitations and a reduction in the amount of interferences that are generated (Figure 4). An 
important point demonstrated by several studies is that not all games allow the same level of 
improvement being those that set players in a first-person shooter scenario would have the higher 
effects. 
 
An amazing example of these ideas is the game that was developed by the Gazzaley Laboratory 
associated with Robert Wood Johnson Foundation called Neuroracer. It comprises the whole idea 
of multitasking and also, it becomes more challenging as time passes and the player moves on in 
the game. Also , this game, o make it a fair evaluation of the improvement, shifted its 
characteristics depending of those of the user.  
Conclusion 
 
Our brain is a changing structure that can be modified and redirected to improve its performance both 
by a pharmacological and non-pharmacological pathway. Pharmacological approaches try the 
recovery of a physiological state that has been altered due to a pathology or, to enhance capabilities 
through the modification of the brain’s physiological environment, whereas the non-pharmacological 
approaches, among them the gaming experiences, work basing themselves on the modification of the 
brain’s network through the creation of external stimulus. 
Figure 1. Degeneration of brain tissue due to 
Alzheimer’s dementia as a result of diffuse 
cerebral atrophy (Rang et al.).  
Figure 2. Variation in brain matter’s percentage 
in hippocampus through out an experiment in 
London’s taxi drivers (J. A. Anguera et al.). 
Figure 3. Positive correlation in the increase of 
brain matter in several visual areas while 
learning to juggle (J. A. Anguera et al.). 
Figure 4. Development of multitasking cost (working 
memory and attention) over life time and during training 
methodologies (J. A. Anguera et al.).   
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